These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 22817915)

  • 21. Biofilm inhibition by Cymbopogon citratus and Syzygium aromaticum essential oils in the strains of Candida albicans.
    Khan MS; Ahmad I
    J Ethnopharmacol; 2012 Mar; 140(2):416-23. PubMed ID: 22326355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Susceptibilities to amphotericin B and fluconazole of Candida species in Taiwan Surveillance of Antimicrobial Resistance of Yeasts 2006.
    Yang YL; Wang AH; Wang CW; Cheng WT; Li SY; Lo HJ;
    Diagn Microbiol Infect Dis; 2008 Jun; 61(2):175-80. PubMed ID: 18304773
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Amphotericin B lipid complex is efficacious in the treatment of Candida albicans biofilms using a model of catheter-associated Candida biofilms.
    Mukherjee PK; Long L; Kim HG; Ghannoum MA
    Int J Antimicrob Agents; 2009 Feb; 33(2):149-53. PubMed ID: 18945596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amphotericin B-induced in vitro postantifungal effect on Candida species of oral origin.
    Ellepola AN
    Med Princ Pract; 2012; 21(5):442-6. PubMed ID: 22678101
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synergistic activity of lysozyme and antifungal agents against Candida albicans biofilms on denture acrylic surfaces.
    Samaranayake YH; Cheung BP; Parahitiyawa N; Seneviratne CJ; Yau JY; Yeung KW; Samaranayake LP
    Arch Oral Biol; 2009 Feb; 54(2):115-26. PubMed ID: 19038377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Sensitivity of yeasts of the genus Candida to new antifungal agents].
    Hernández-Molina JM; Llosá J; Martínez-Brocal A; de la Rosa M
    Enferm Infecc Microbiol Clin; 1991; 9(7):405-8. PubMed ID: 1799609
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigation of the in vitro antifungal and antibiofilm activities of ceragenins CSA-8, CSA-13, CSA-44, CSA-131, and CSA-138 against Candida species.
    Bozkurt-Guzel C; Hacioglu M; Savage PB
    Diagn Microbiol Infect Dis; 2018 Aug; 91(4):324-330. PubMed ID: 29680320
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The trend of susceptibilities to amphotericin B and fluconazole of Candida species from 1999 to 2002 in Taiwan.
    Yang YL; Li SY; Cheng HH; Lo HJ;
    BMC Infect Dis; 2005 Nov; 5():99. PubMed ID: 16266438
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro antifungal activity of phenothiazines and their combination with amphotericin B against different Candida species.
    Galgóczy L; Bácsi A; Homa M; Virágh M; Papp T; Vágvölgyi C
    Mycoses; 2011 Nov; 54(6):e737-43. PubMed ID: 21605196
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro synergism between berberine and miconazole against planktonic and biofilm Candida cultures.
    Wei GX; Xu X; Wu CD
    Arch Oral Biol; 2011 Jun; 56(6):565-72. PubMed ID: 21272859
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of amphotericin B alone or in combination with rifampicin or clarithromycin against Candida species biofilms.
    Del Pozo JL; Francés ML; Hernáez S; Serrera A; Alonso M; Rubio MF
    Int J Artif Organs; 2011 Sep; 34(9):766-70. PubMed ID: 22094555
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro effects of micafungin against Candida biofilms on polystyrene and central venous catheter sections.
    Seidler M; Salvenmoser S; Müller FM
    Int J Antimicrob Agents; 2006 Dec; 28(6):568-73. PubMed ID: 17101265
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Amphotericin B susceptibility of Candida species assessed by rapid flow cytometric membrane potential assay.
    Ordóñez JV; Wehman NM
    Cytometry; 1995 Jun; 22(2):154-7. PubMed ID: 7587748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro susceptibility and resistance of Candida spp. to hamycin.
    Athar MA
    Sabouraudia; 1971 Nov; 9(3):256-62. PubMed ID: 4944203
    [No Abstract]   [Full Text] [Related]  

  • 35. Absence of amphotericin B-tolerant persister cells in biofilms of some Candida species.
    Al-Dhaheri RS; Douglas LJ
    Antimicrob Agents Chemother; 2008 May; 52(5):1884-7. PubMed ID: 18285487
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro studies of anticandidal activity of goniothalamin enantiomers.
    Martins CV; de Resende MA; da Silva DL; Magalhães TF; Modolo LV; Pilli RA; de Fátima A
    J Appl Microbiol; 2009 Oct; 107(4):1279-86. PubMed ID: 19486403
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A comparative in vitro study of amphotericin B 1 clotrimazole and 5-fluorocytosine against clinically isolated yeasts.
    Hamilton-Miller JM
    Sabouraudia; 1972 Nov; 10(3):276-83. PubMed ID: 4565443
    [No Abstract]   [Full Text] [Related]  

  • 38. In vitro activity of amphotericin B against Candida lusitaniae clinical isolates.
    Prigitano A; Biraghi E; Pozzi C; Viviani MA; Tortorano AM
    J Chemother; 2010 Feb; 22(1):71-2. PubMed ID: 20227999
    [No Abstract]   [Full Text] [Related]  

  • 39. Potentiation of rifampicin and 5-fluorocytosine as antifungal antibiotics by amphotericin B (yeast-membrane permeability-ribosomal RNA-eukaryotic cell-synergism).
    Medoff G; Kobayashi GS; Kwan CN; Schlessinger D; Venkov P
    Proc Natl Acad Sci U S A; 1972 Jan; 69(1):196-9. PubMed ID: 4550505
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Iron-limited biofilms of Candida albicans and their susceptibility to amphotericin B.
    Baillie GS; Douglas LJ
    Antimicrob Agents Chemother; 1998 Aug; 42(8):2146-9. PubMed ID: 9687427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.